Yatharth Hospital AGM update and ₹3,150 cr EGM vote

What the latest disclosures signal

Yatharth Hospital and Trauma Care Services Ltd has released updates tied to its shareholder meetings, including the proceedings of its 19th Annual General Meeting (AGM) held on September 25, 2026. Alongside the AGM-related filings, the company has also circulated newspaper publications of the AGM notice and e-voting information.

The AGM disclosures arrive at a time when the company is also seeking shareholder approval for a large capital raise. Yatharth has announced an Extraordinary General Meeting (EGM) scheduled for October 15, 2026 to vote on a preferential issue linked to an Advent International affiliate.

19th AGM held on September 25, 2026

In its filing, the company said it is submitting a summary of the proceedings of the 19th AGM held on September 25, 2026. It also submitted the newspaper publication of the notice for the 19th AGM, along with e-voting information.

These filings are part of routine compliance for listed companies, but they also help investors track how resolutions were placed before shareholders and how voting access was provided. The company has additionally flagged “Voting Results of the 19th Annual General Meeting” as an announcement dated September 25.

Voting results and scrutinizer documentation

Yatharth’s exchange disclosures list the “Shareholder Meeting / Postal Ballot-Scrutinizer’s Report” dated September 25, 2026, alongside the AGM voting results disclosure. While the provided text does not include the detailed resolution-by-resolution outcome, it indicates that the company has filed the formal documentation connected to the AGM process.

Separately, the company also referenced historical AGM documentation, including the scrutinizer’s report and proceedings summary for its 18th AGM held on September 30, 2025. These older references underscore that the current set of filings is being maintained within a broader trail of shareholder communication and meeting records.

Trading window closure ahead of results

Among the listed announcements, Yatharth also disclosed a closure of the trading window. The announcement dated September 28 states that the trading window closes from October 1, 2026, ahead of the Q2 and half-year results.

Such closures are typically used to restrict trading by insiders and connected persons during periods when unpublished price sensitive information may exist, such as the finalisation of quarterly or half-yearly financial results.

Preferential issue: ₹3,150 crore fundraise to Rasmalai Limited

A key corporate action disclosed by the company is a proposed preferential issue to Rasmalai Limited, described as an Advent International affiliate. According to the filing, Yatharth Hospital will raise ₹3,150 crore via the preferential issue.

The company said the funds are earmarked for expanding its hospital network, healthcare infrastructure, and general corporate purposes. The disclosure positions the capital raise as a growth and capacity-building step, linked to the company’s hospital operations in North India.

Deal structure: stake, price, and instruments

Yatharth’s board approved a “significant preferential issue” of equity shares and warrants to Rasmalai Limited, raising ₹3,150 crore for a 24.87% diluted stake. The filing also specifies a price of ₹985.17 per security for the proposed issuance.

The text further notes that the preferential issue is proposed to Rasmalai Limited of Cyprus. The company has linked the next step to shareholder approval, to be sought at the EGM on October 15, 2026.

MoA/AoA changes and shareholder approval at EGM

In a separate disclosure under Regulation 30 (LODR) relating to amendments to the Memorandum and Articles of Association (MoA/AoA), the company said amendments were approved to grant special rights to the new investor and promoters, pending shareholder approval.

The same set of filings indicates that the EGM on October 15, 2026 is the forum where shareholders will vote on these resolutions. The company has also listed a “Notice of 1st 2026-27 Extra-ordinary General Meeting of the Company” dated September 22, 2026.

Authorised share capital increase

The board also approved an increase in authorised share capital from ₹115 crore to ₹150 crore, according to the disclosure. Such increases are commonly used to ensure the company has sufficient authorised headroom to issue new securities.

This step is presented alongside the preferential issue proposal, suggesting it is part of the enabling actions required to execute the transaction, subject to shareholder approval.

Governance rights and promoter lock-in

The disclosure also refers to an investment agreement that would grant the investor up to two board seats and reserved-matter rights. Additionally, it mentions a three-year lock-in for promoters.

These elements are notable for investors assessing governance and control dynamics post-transaction, because board representation and reserved-matter protections can shape how major corporate decisions are taken after the investment.

Company footprint and operating context

Yatharth Hospital and Trauma Care Services Limited was incorporated in 2008. The text describes the company as operating multi-care hospitals in Noida, Greater Noida, and Noida Extension in Uttar Pradesh.

It also says Yatharth operates a network of multi-specialty and super-specialty hospitals primarily in North India, with a focus on tertiary care, trauma services, and advanced treatments. This operational profile is relevant to understanding how the proposed funds may be deployed toward infrastructure and network expansion.

Key dates and disclosures at a glance

Market impact

The disclosures centre on process and governance rather than day-to-day operations. For shareholders, the immediate market relevance is the proposed ₹3,150 crore preferential issue at ₹985.17 per security, the indication of a 24.87% diluted stake for the incoming investor, and the associated governance provisions.

The trading window closure from October 1, 2026 is also material for market participants as it signals a defined compliance period ahead of Q2 and half-year results. Separately, the authorised share capital increase from ₹115 crore to ₹150 crore points to structural preparation for the proposed issuance.

Analysis: why the EGM vote matters

The scheduled October 15, 2026 EGM is the key upcoming milestone because it will determine whether shareholders approve the preferential issue and associated changes, including MoA/AoA amendments. The transaction also includes an investment agreement framework that contemplates up to two board seats for the investor and reserved-matter rights.

From a capital allocation perspective, the company has stated the proceeds are intended for hospital network expansion, healthcare infrastructure, and general corporate purposes. For investors, the disclosures provide a clear checklist of what is being asked of shareholders and what governance and capital structure changes could accompany the fundraise.

Conclusion

Yatharth Hospital’s latest filings bring together AGM compliance disclosures and a high-value capital raise that now hinges on shareholder approval. The company has reported the proceedings of its 19th AGM held on September 25, 2026, and it has set October 15, 2026 as the EGM date to vote on the ₹3,150 crore preferential issue to Rasmalai Limited and related corporate changes.

The next confirmed step is the EGM, where shareholders will consider the preferential issue, the authorised share capital increase, and the proposed amendments to the MoA and AoA described in the company’s disclosures.